Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDARAVONE vs EFAVIRENZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDARAVONE vs EFAVIRENZ: Safety Overview

Metric EDARAVONE EFAVIRENZ
Total FAERS Reports 3,762 7,893
Deaths Reported 1,137 962
Death Rate 30.2% 12.2%
Hospitalizations 495 1,528
Average Patient Age 65.0 yrs 40.7 yrs
% Female Patients 41.5% 37.7%
FDA Approval Date Dec 23, 2024 Apr 27, 2018
Manufacturer Gland Pharma Limited Camber Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued